IRCT2015090423887N1已完成早期 1 期
Evaluation the effect of silimaryn in improvement of hepatic and platlet damage in severe preeclampsia
试验速览
- 阶段
- 早期 1 期
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 30 years（—）
- 性别
- Female
入选标准
- •age between 20 and 30 years; BMI is to be 20 to 24;Gestational age is between 35 and 42 weeks at the time of termination of pregnancy; blood pressure before the termination of pregnancy is to be more than 90/140 mm Hg;The presence of Proteinuria in random urine samples before pregnancy termination; no history of hypertension, diabetes, kidney disease, Collagen vascular and other types of cardiovascular diseases; mother is supposed to be nulliparous; Singleton pregnancy not molar; termination of pregnancy is indicated By severe pre-eclampsia
- •Exclusion criteria:presence of preeclampsia in mother
排除标准
- 未提供
研究者
相似试验
已完成
2 期
To evaluate the effectiveness of Silymarin (Livergol) on IL-6 levels and size of endometrioma lesionsIRCT20150905023897N5Vice chancellor for research Tarbiat Modares University60
招募中
3 期
Silymarin in multiple SclerosisTherapeutic effect of silymarin.IRCT20171220037977N1Esfahan University of Medical Sciences60
尚未招募
2 期
Silymarin capsule in COVID-19COVID-19 disease.COVID-19U07.1IRCT20180103038199N10Mashhad University of Medical Sciences140
尚未招募
3 期
Effect of silymarin in inflammatory bowel diseaseK50-K52Inflammatory Bowel Disease.Noninfective inflammatory bowel diseaseIRCT20101107005123N3Mashhad University of Medical Sciences40
已完成
2 期
Effect of Silymarin in prevention of contrast nephropatyephropathy.Nephropathy induced by other drugs, medicaments and biological substancesIRCT2014051117648N1Isfahan University of Medical Sciences200